VaneJRMitchellJAAppletonITomlinsonABishop-BaileyDCroxtallJInducible isoforms of cyclooxygenase and nitric oxide synthase in inflammation. Proc Natl Acad Sci USA1994;91:2046–50.
3.
GarrettNEMappPICruwysSCKiddBLBlakeDR. Role of substance P in inflammatory arthritis. Annal Rheum Dis1992;51:1014–18.
4.
WahlSMArendWPRossR. The effect of complement depletion on wound healing. Am J Pathol1974;75(1):73–90.
5.
SimpsonDMRossR. The neutrophilic leukocyte in wound repair: A study with antineutrophil serum. J Clin Invest1972;51(8):2009–23.
6.
PettipherERHiggsGAHendersonB. Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci USA1986;83:8749–53.
7.
JaattelaM. Biologic activities and mechanisms of action of tumor necrosis factor-αa/cachectin. Lab Invest1991;64:724–42.
8.
RobertsCJBirkenmeierTMMcQuillanJJAkiyamaSKYamadaSSChenW-TTransforming growth factor β stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts. J Cell Biol1988;263:4586–92.
9.
VlodavskyIFuksZIshai-MichaeliRBashkinPLeviEKornerGExtracellular matrix-resident basic fibroblast growth factor: Implication for the control of angiogenesis. J Cell Biochem1991;45:167–76.
10.
KnorrMSchullerSSteuhlKPThielHJ. EGF in therapy of corneal diseases. Principles and possible uses. Opthalmologe1992;89:119–27.
11.
FalangaVEaglsteinWHBucaloBKatzMHHarrisBCarsonP. Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers. J Dermatol Surg Oncol1992;18:604–6.
12.
PierceGFVande-BergJRudolphRTarpleyJMustoeTA. Platelet-derived growth factor-BB and transforming growth factor beta 1 selectively modulate glycosaminoglycans, collagen, and myofibroblasts in excisional wounds. Am J Pathol1991;138:629–46.
13.
WahlSMAllenJBCostaGLWongHLDaschJR. Reversal of acute and chronic synovial inflammation by anti-transforming growth factor β. J Exp Med1993;177:225–30.
14.
Rubbia-BrandtLSappinoAPGabbianiG. Locally applied GM-CSF induces the accumulation of α-smooth muscle actin containing myofibroblasts. Virchows Arch B Cell Pathol1991;60:73–82.
15.
YanagisawaMKuriharaHKimuraSTomoteYKobayashiMMitsuiYA novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature1988;332:411–15.
16.
AppletonITomlinsonAChanderCLWilloughbyDA. Effect of endothelin-1 on croton oil-induced granulation tissue in the rat. A pharmacologic and immunohistochemical study. Lab Invest1992;67(6):703–10.
17.
ThiemermannCCorderR. Is endothelin-1 the regulator of myofibroblast contraction during wound healing?Lab Invest1992;67:677–9.
18.
DarbyISkalliOGabbianiG. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest1990;63:21–9.
19.
DuncanMRBermanB. Differential regulation of glycosaminoglycan, fibronectin and collagenase production in cultured dermal fibroblasts by interferon-alpha, -beta and -gamma. Arch Dermatol Res1989;281:11–18.
20.
HaralsonMA. Extracellular matrix and growth factors: An integrated interplay controlling tissue repair and progression to disease. Lab Invest1993;69(4):369–72.
21.
AppletonITomlinsonAColville-NashPRWilloughbyDA. Temporal and spatial immunolocalization of cytokines in murine chronic granulomatous tissue. Implications for their role in tissue development and repair processes. Lab Invest1993;69:405–14.
